Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 cells

Esin Güvenir Çelik(Bilecik Şeyh Edebali Üniversitesi), Onur Eroğlu(Bilecik Şeyh Edebali Üniversitesi)
Research Square
August 22, 2022
10.21203/rs.3.rs-1954138/v1
Cited by 0

Related Papers

Erratum
|Gynecologic and Obstetric Investigation|2015|0